Related Experiment Video
Updated: May 21, 2026
08:37
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
ABHD11-AS1 Suppresses Colorectal Cancer Progression by Disrupting EIF4E-mediated POU2F1 Ubiquitination
Shizhen Li1,2, Xianjie Jiang1,2, Linda Oyang1,2
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
International Journal of Biological Sciences
|May 20, 2026
Summary
A novel long non-coding RNA, ABHD11-AS1, acts as a tumor suppressor in colorectal cancer (CRC). Its downregulation promotes CRC progression and chemoresistance, revealing a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a major global health concern with incompletely understood progression mechanisms.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer regulation.
- Identifying novel regulatory pathways is crucial for developing effective CRC therapies.
Purpose of the Study:
- To investigate the role of ABHD11-AS1, a specific lncRNA, in colorectal cancer.
- To elucidate the molecular mechanisms underlying ABHD11-AS1's function in CRC.
- To assess the therapeutic potential of ABHD11-AS1 in CRC treatment.
Main Methods:
- Gene expression analysis in CRC tissues.
- In vitro functional assays (proliferation, migration, invasion).
- Chemotherapy sensitivity assays.
- Molecular mechanism studies involving protein-protein interactions and translation regulation.
Main Results:
- ABHD11-AS1 was found to be significantly downregulated in CRC tissues, correlating with poor prognosis.
- ABHD11-AS1 suppressed CRC cell proliferation, migration, and invasion, and increased oxaliplatin sensitivity.
- ABHD11-AS1 inhibits USP18 translation by disrupting EIF4E phase separation, leading to POU2F1 degradation.
Conclusions:
- ABHD11-AS1 functions as a tumor suppressor in colorectal cancer.
- The ABHD11-AS1/EIF4E/USP18/POU2F1 axis represents a novel regulatory pathway in CRC.
- ABHD11-AS1 holds promise as a potential therapeutic target for CRC, enhancing treatment efficacy.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.